Dimai, Hans P.
Johansson, Helena
Harvey, Nicholas C.
Lorentzon, Mattias
Liu, Enwu
Vandenput, Liesbeth
Fahrleitner-Pammer, Astrid
Pietschmann, Peter
Muschitz, Christian
McCloskey, Eugene V.
Kanis, John A.
Article History
Received: 27 July 2022
Accepted: 4 October 2022
First Online: 11 November 2022
Declarations
:
: HP Dimai has received lecture and consultancy fees from Amgen, Braincon, Daiichi-Sankyo, Eli Lilly, Gedeon Richter, Genericon, Medtronic, Merck Sharp & Dohme, Novartis, Nycomed, Sanabo, Servier, Sinapharm, Stada, UCB, all outside the presented work.NC Harvey has received consultancy, lecture fees and honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, Servier, Shire, UCB, Kyowa Kirin, Consilient Healthcare, Radius Health and Internis Pharma.C Muschitz has received speaker honoraria from Amgen, Novartis, Servier, Eli Lilly, Nycomed Pharma/Takeda, Kwizda Pharma, Boehringer Ingelheim, Actavis and Daiichi Sankyo, all outside the presented work.M Lorentzon has received lecture fees from Amgen, Lilly, Meda, Renapharma, UCB Pharma, and consulting fees from Amgen, Radius Health, UCB Pharma, Renapharma and Consilient Health, all outside the presented work.A Fahrleitner-Pammer has received research grants from Amgen and Roche, and lecture fees from Amgen, Alexion, EliLilly, Gedeon Richter, Fresenius, Stada, UCB, all outside the presented work.C Muschitz has received speaker honoraria from Amgen, Novartis, Servier, Eli Lilly, Nycomed Pharma/Takeda, Kwizda Pharma, Boehringer Ingelheim, Actavis and Daiichi Sankyo, all outside the presented work.EV McCloskey has received consultancy/lecture fees/grant funding/honoraria from AgNovos, Amgen, AstraZeneca, Consilient Healthcare, Fresenius Kabi, Gilead, GSK, Hologic, Internis, Lilly, Merck, Novartis, Pfizer, Radius Health, Redx Oncology, Roche, SanofiAventis, Servier, Synexus, UCB, Viiv, Warner Chilcott, I3 Innovus and Unilever.JA Kanis is the architect of FRAX but has no financial interest.P Pietschmann, E Liu, L Vandenput and H Johansson have no competing interests to declare.